Subingsubing, Matt .

HRN: 20-78-26  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2026
CEFUROXIME 1.5GM (VIAL)
02/15/2026
02/21/2026
IV
440mg
Q8
URTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: